Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Research Center of the Sainte-Justine University Hospital, University of Montreal, Montreal, Quebec, Canada.
Nat Rev Endocrinol. 2022 Feb;18(2):96-110. doi: 10.1038/s41574-021-00593-z. Epub 2021 Nov 23.
Vitamin D supplementation can prevent and cure nutritional rickets in infants and children. Preclinical and observational data suggest that the vitamin D endocrine system has a wide spectrum of skeletal and extra-skeletal activities. There is consensus that severe vitamin D deficiency (serum 25-hydroxyvitamin D (25OHD) concentration <30 nmol/l) should be corrected, whereas most guidelines recommend serum 25OHD concentrations of >50 nmol/l for optimal bone health in older adults. However, the causal link between vitamin D and many extra-skeletal outcomes remains unclear. The VITAL, ViDA and D2d randomized clinical trials (combined number of participants >30,000) indicated that vitamin D supplementation of vitamin D-replete adults (baseline serum 25OHD >50 nmol/l) does not prevent cancer, cardiovascular events, falls or progression to type 2 diabetes mellitus. Post hoc analysis has suggested some extra-skeletal benefits for individuals with vitamin D deficiency. Over 60 Mendelian randomization studies, designed to minimize bias from confounding, have evaluated the consequences of lifelong genetically lowered serum 25OHD concentrations on various outcomes and most studies have found null effects. Four Mendelian randomization studies found an increased risk of multiple sclerosis in individuals with genetically lowered serum 25OHD concentrations. In conclusion, supplementation of vitamin D-replete individuals does not provide demonstrable health benefits. This conclusion does not contradict older guidelines that severe vitamin D deficiency should be prevented or corrected.
维生素 D 补充剂可预防和治疗婴幼儿营养性佝偻病。临床前和观察性数据表明,维生素 D 内分泌系统具有广泛的骨骼和骨骼外活性。人们普遍认为应纠正严重的维生素 D 缺乏症(血清 25-羟维生素 D(25OHD)浓度<30nmol/L),而大多数指南建议老年人血清 25OHD 浓度>50nmol/L 以达到最佳骨骼健康。然而,维生素 D 与许多骨骼外结果之间的因果关系仍不清楚。VITAL、ViDA 和 D2d 随机临床试验(参与者总数超过 30000 人)表明,维生素 D 补充剂对维生素 D 充足的成年人(基线血清 25OHD>50nmol/L)不能预防癌症、心血管事件、跌倒或进展为 2 型糖尿病。事后分析表明,维生素 D 缺乏症患者可能有一些骨骼外的益处。超过 60 项孟德尔随机研究旨在最小化混杂引起的偏倚,评估了终生遗传性血清 25OHD 浓度降低对各种结果的影响,大多数研究发现无显著影响。四项孟德尔随机研究发现,遗传性血清 25OHD 浓度降低的个体多发性硬化症的风险增加。总之,补充维生素 D 并不能提供明显的健康益处。这一结论并不与旧的指南相矛盾,即应预防或纠正严重的维生素 D 缺乏症。